We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $113B
1-Year Est. Return 38.87%
This Fund
S&P 500
This Quarter Est. Return
+2.73%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$67.2B
AUM Growth
+$540M
Cap. Flow
-$425M
Cap. Flow %
-0.63%
Top 10 Hldgs %
16.83%
Holding
780
New
63
Increased
245
Reduced
379
Closed
79

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$840M
2
RTX icon
RTX Corp
RTX
+$638M
3
TT icon
Trane Technologies
TT
+$326M
4
APC
Anadarko Petroleum
APC
+$299M
5
GILD icon
Gilead Sciences
GILD
+$274M

Sector Composition

Rank Sector Weight
1 Financials 24.95%
2 Healthcare 16.68%
3 Technology 16.63%
4 Industrials 11.79%
5 Consumer Discretionary 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TFC icon
26
Truist Financial
TFC
$61.4B
$626M 0.93%
16,047,513
+2,673,160
+20% +$101M
MPC icon
27
Marathon Petroleum
MPC
$102B
$622M 0.93%
12,140,402
+452,026
+4% +$21.7M
CB icon
28
Chubb
CB
$131B
$620M 0.92%
5,561,113
-193,975
-3% -$21.8M
DFS
29
DELISTED
Discover Financial Services
DFS
$616M 0.92%
10,928,231
+1,827,619
+20% +$108M
OCR
30
DELISTED
OMNICARE INC
OCR
$589M 0.88%
7,647,699
+54,010
+0.7% +$4.1M
FITB
31
Fifth Third Bancorp
FITB
$49.7B
$586M 0.87%
31,108,491
-10,538,442
-25% -$199M
TEVA icon
32
Teva Pharmaceuticals
TEVA
$43.8B
$560M 0.83%
8,993,700
-206,302
-2% -$12M
RTN
33
DELISTED
Raytheon Company
RTN
$532M 0.79%
4,872,829
-176,647
-3% -$19M
OXY icon
34
Occidental Petroleum
OXY
$59.1B
$532M 0.79%
7,303,958
-50,251
-0.7% -$3.89M
M icon
35
Macy's
M
$5.92B
$529M 0.79%
8,142,099
-345,643
-4% -$22.2M
TRV icon
36
Travelers Companies
TRV
$77B
$525M 0.78%
4,858,469
-155,174
-3% -$16.6M
TSN icon
37
Tyson Foods
TSN
$19.5B
$513M 0.76%
13,388,518
+1,534,711
+13% +$61.4M
BRCD
38
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$490M 0.73%
41,294,564
-1,176,288
-3% -$14M
EGN
39
DELISTED
Energen
EGN
$449M 0.67%
6,801,086
+253,795
+4% +$16.3M
AON icon
40
Aon
AON
$74.2B
$442M 0.66%
4,598,111
+635,843
+16% +$61.5M
DAL icon
41
Delta Air Lines
DAL
$53.4B
$431M 0.64%
9,591,110
+123,076
+1% +$5.71M
CCK icon
42
Crown Holdings
CCK
$12.8B
$431M 0.64%
7,974,334
-1,094,323
-12% -$54.4M
ABBV icon
43
AbbVie
ABBV
$456B
$422M 0.63%
7,215,366
+1,476,631
+26% +$89.2M
GILD icon
44
Gilead Sciences
GILD
$185B
$417M 0.62%
4,246,579
+2,694,732
+174% +$274M
GPK icon
45
Graphic Packaging
GPK
$3.35B
$416M 0.62%
28,592,052
+2,720,914
+11% +$39.8M
AES icon
46
AES
AES
$10.5B
$410M 0.61%
31,916,333
+1,664,034
+6% +$20.8M
FIS icon
47
Fidelity National Information Services
FIS
$20.9B
$409M 0.61%
6,010,326
+11,027
+0.2% +$721K
EQT icon
48
EQT Corp
EQT
$34.3B
$404M 0.6%
8,964,621
-925,939
-9% -$39.3M
CNQ icon
49
Canadian Natural Resources
CNQ
$103B
$390M 0.58%
26,247,050
+1,164,476
+5% +$16.7M
ON icon
50
ON Semiconductor
ON
$29.1B
$385M 0.57%
31,811,039
-6,821,100
-18% -$78.1M

Similar funds

Boston Partners's Q1 2015 Portfolio in Review

As of Q1 2015, Boston Partners held 780 positions worth $67.2B, up 0.81% from $66.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Partners's Q1 2015 filing shows 63 new, 245 increased, 379 reduced and 79 closed positions. Its largest new stake was Merck: 14,837,117 shares worth $814M. The largest sale was Citigroup, an estimated $489M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Technology.

  • Boston Partners's largest Q1 2015 buy was Merck: 14,837,117 shares worth $814M.
  • Boston Partners added most to RTX Corp in Q1 2015, an estimated $638M increase.
  • Boston Partners's biggest Q1 2015 reduction was Citigroup, cutting an estimated $489M.
  • Boston Partners fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $397M.
  • Boston Partners's ten largest holdings make up 17% of its $67.2B portfolio in Q1 2015.
  • Boston Partners opened 63 new positions and closed 79 in Q1 2015.
  • Boston Partners's portfolio value rose 0.81% quarter-over-quarter to $67.2B.

Based on Boston Partners's 13F filing for Q1 2015, filed 5 May 2015.